With millions of people set to have robotic surgery it’s vital that power supplies are reliable and uninterruptible.
The U.S. Food and Drug Administration on Thursday announced the names of nine products, under a new fast-track review process ...
Achieve Life Sciences (ACHV) and Disc Medicine (IRON) stocks rally after getting selected among winners of initial FDA ...
The FDA has handed out the first nine national priority vouchers, positioning companies including Merck KGaA, Regeneron and Sanofi to complete the approval process in one to two months.
A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...
The firm will launch a Phase I trial in healthy volunteers in the Netherlands to establish safety and proof-of-target engagement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback